Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Cellular Immunology
|
May 1, 1988
Virus-specific memory T cells are Pgp-1+ and can be selectively activated with phorbol ester and calcium ionophore
Z Tabi, F Lynch, R Ceredig, et al.
Vaccine
|
November 4, 2008
A clinical grade poly I:C-analogue (Ampligen) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro
H Navabi, B Jasani, A Reece, et al.
Vaccine
|
March 10, 2005
The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer
M Adams, H Navabi, D Croston, et al.
Blood Cells, Molecules & Diseases
|
August 3, 2005
Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial
H Navabi, D Croston, J Hobot, et al.
Nanoscale
|
April 26, 2018
Rab35-dependent extracellular nanovesicles are required for induction of tumour supporting stroma
V Yeung, J P Webber, E A Dunlop, et al.
Oncogene
|
January 21, 2014
Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes
J P Webber, L K Spary, A J Sanders, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Cellular Immunology
|
May 1, 1988
Virus-specific memory T cells are Pgp-1+ and can be selectively activated with phorbol ester and calcium ionophore
Z Tabi, F Lynch, R Ceredig, et al.
Vaccine
|
November 4, 2008
A clinical grade poly I:C-analogue (Ampligen) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro
H Navabi, B Jasani, A Reece, et al.
Vaccine
|
March 10, 2005
The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer
M Adams, H Navabi, D Croston, et al.
Blood Cells, Molecules & Diseases
|
August 3, 2005
Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial
H Navabi, D Croston, J Hobot, et al.
Nanoscale
|
April 26, 2018
Rab35-dependent extracellular nanovesicles are required for induction of tumour supporting stroma
V Yeung, J P Webber, E A Dunlop, et al.
Oncogene
|
January 21, 2014
Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes
J P Webber, L K Spary, A J Sanders, et al.
Page
of 2